Although the overall incidence and mortality rates of colorectal cancer (CRC) have been decreasing in Australia over the last 20 years, there has been a significant increase in the incidence of early-onset CRC (EOCRC) without a clear explanation. In this review, we have outlined the epidemiology, suggested risk factors, clinicopathological and molecular features, survival and prognosis, and treatment approach for Australian young adults with CRC.
INTRODUCTION
In Australia, colorectal cancer (CRC) was estimated to be the most frequently diagnosed digestive-tract cancer in 2018 and was Australia's most frequent digestive-tract cancer killer [1] . CRC is the third most commonly diagnosed cancer and the second leading cause of cancer death worldwide [2] . The age distribution, however, has altered with an increase in incidence of early-onset CRC (EOCRC) being reported in Australia, the USA and many other developed countries [3] [4] [5] [6] [7] [8] [9] .
There is a difference in the literature regarding the exact definition of early onset as different researchers have used various age groups including individuals under The prevalence of CRC is not uniform across all racial and ethnic groups, though there is an increase in the prevalence of this disease across the entire population. This variation in proportion of CRC occuring at an earlier age may reflect the expected lifespan of these sub-group in particular countries, as well as genetic background and a greater sensitivity to Western lifestyle risk factors (Table 1) . For example, in the USA, incidence rates were reported to be higher among African
Americans aged between 20-40 years than non-Hispanic Table   2 ). SPS accounts for a currently unknown proportion of EOCRC.
Risk Factors and Microbiota
Different lifestyle-related risk factors including obesity and diabetes have been associated with the significant increase in the prevalence of EOCRC ( 
Risk factor Higher risk percentage Author

Inflammatory bowel diseases (IBDs)
People with IBDs have a two to threefold higher risk of developing CRC.
[107]
Diabetes mellitus
Higher risk of developing CRC compared to general population (HR, 1.3, 95%CI 1.2-1.5).
[106]
Solid Organ Transplantation The increase of proximal colon tumour (SIR=1.69, 95%CI: 1.53-1.87).
[108]
Appendicitis
Appendicitis patients have a higher risk of CRC (SIR 4.6, 95% CI 4.0-5.2; SIR 3.5, 95% CI 2.9-4.1).
[109]
Physical Inactivity
Least active individuals are by 27% at higher risk of susceptibility to CRC.
[110]
Obesity
Obese or overweight women have double the risk of developing bowel cancer under age 50 years compared to healthy body weight women.
[111]
Meat Consumption
Red meat and processed meat increase the risk of CRC by 30% and 20%, respectively.
[112]
Fibre
Swedish women with a high intake of vegetables and fruits had 32% risk reduction for bowel cancer.
[113]
Calcium T risk of CRC was about 70% lower in people with the highest consumption of Ca+2 compared to people with the lowest calcium intake.
[114]
Vitamin D There was a considerably lower risk of developing CRC in people with a high blood level of vitamin D (1,25(OH)2D3) and high lymphocyte accounts.
[115]
Alcohol A modest increased risk of colon tumour (45%) and rectal tumour (49%) with regular high intake of alcohol (>45 g/day) in both genders combined in relative non-drinkers.
[116]
Smoking
Smokers were 2-fold at higher risk of advanced neoplasia than non-smokers, similar to or higher than those patients that have the first-degree relative with this disease. [117, 118] DOI: https://doi.org/10.30654/MJCS.10018 6 adults have increased in parallel to the increase in EOCRC, and an independent relationship is yet to be clearly demonstrated. [124] . Other studies found that F. nucleatum travels as bowel cancer metastasizes in mice, and murine cancers with this bacterium respond to the metronidazole antibiotic [125] .
However, while it can be postulated that microbiota might be involved, there is not yet much convincing evidence in an area which is difficult to research. Also, it is currently not known whether the microbiota has a role in EOCRC. [167, 168] . Somatic mutations of the KRAS gene are found in about 35% to 45% of CRCs [169] and predict a lack of response to anti-EGFR targeted therapy [170] [171] [172] . In EOCRC, the incidence of KRAS mutations remains questionable, with the incidence of these mutations ranging from 4% to 54% in EOCRCs ultimately the therapeutic strategy will be guided by the exact profile rather than age. 
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